Clinical Trials Associate II | Anaheim, CA

Viejo, California, and we have additional locations in the United States, Canada, United Kingdom, Germany, Japan, Australia and Brazil. How will you make an impact? The Clinical Trials Associate is responsible for the coordination of clinical research studies in compliance with U.

S. and international regulations under the guidance of a Clinical Manager or Clinical Director. What Will you do? Clinical Trial Coordination Assists with the development of clinical trial protocols Assists with development of case report forms Assists with analyses of study data Reviews and Monitors Clinical Study Data Reviews data as it comes in from sites Documents errors and communicates to Manager

and Director Clinical Operations Assists Manager with study management Study Master File Maintenance Sets up Study Master File and Study Master File Tracker Receives, QC's, scans and files documents in Study Master File Provides status of documents to Clinical Management Collection of site start-up documents Prepares Regulatory Binders and provides to sites Receives, QCs, scans and files site documents in Study Master File Provides status of site documents in Study Master File t Establishes and maintains tracking of critical trial information Enrollment trackers Adverse event trackers Site payment trackers and site payments Team Support Scheduling meetings, set up of AV, teleconference

or video conference equipment Preparation of relevant material Support IP shipment and shipment of other materials to sites How Will you Get There?

Bachelor's degree with background in sciences preferred, or equivalent work experience Minimum of 2 years of work experience as a CTA CTA must demonstrate the following: Understanding of required regulatory documents for the study. Effective communication and understanding of the role with sites; with both monitors and CRMs. Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family.

Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others. We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class!

Moreover, Glaukos Corporation has been Certified as a Great Place to Work the last two years! Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, interaction including interactionual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.

ABOUT US Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and medical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma.

In 2012, we launched our first MIGS device-the i Stent®-in the United States, followed by our next-generation i Stent inject® device in September 2018 and i Stent inject® W in September 2020. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and medical therapies for glaucoma, corneal health, and retinal diseases. Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol " GKOS" Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts.

Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, interaction including interactionual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.